530 related articles for article (PubMed ID: 26075791)
1. A method to predict the impact of regulatory variants from DNA sequence.
Lee D; Gorkin DU; Baker M; Strober BJ; Asoni AL; McCallion AS; Beer MA
Nat Genet; 2015 Aug; 47(8):955-61. PubMed ID: 26075791
[TBL] [Abstract][Full Text] [Related]
2. Predicting enhancer activity and variant impact using gkm-SVM.
Beer MA
Hum Mutat; 2017 Sep; 38(9):1251-1258. PubMed ID: 28120510
[TBL] [Abstract][Full Text] [Related]
3. Convolutional neural network model to predict causal risk factors that share complex regulatory features.
Lee T; Sung MK; Lee S; Yang W; Oh J; Kim JY; Hwang S; Ban HJ; Choi JK
Nucleic Acids Res; 2019 Dec; 47(22):e146. PubMed ID: 31598692
[TBL] [Abstract][Full Text] [Related]
4. Quantifying deleterious effects of regulatory variants.
Li S; Alvarez RV; Sharan R; Landsman D; Ovcharenko I
Nucleic Acids Res; 2017 Mar; 45(5):2307-2317. PubMed ID: 27980060
[TBL] [Abstract][Full Text] [Related]
5. Integrative Genomic Analysis Predicts Causative
Zhang Y; Manjunath M; Zhang S; Chasman D; Roy S; Song JS
Cancer Res; 2018 Apr; 78(7):1579-1591. PubMed ID: 29351903
[TBL] [Abstract][Full Text] [Related]
6. Mining the Unknown: Assigning Function to Noncoding Single Nucleotide Polymorphisms.
Nishizaki SS; Boyle AP
Trends Genet; 2017 Jan; 33(1):34-45. PubMed ID: 27939749
[TBL] [Abstract][Full Text] [Related]
7. GERV: a statistical method for generative evaluation of regulatory variants for transcription factor binding.
Zeng H; Hashimoto T; Kang DD; Gifford DK
Bioinformatics; 2016 Feb; 32(4):490-6. PubMed ID: 26476779
[TBL] [Abstract][Full Text] [Related]
8. TAGOOS: genome-wide supervised learning of non-coding loci associated to complex phenotypes.
González A; Artufel M; Rihet P
Nucleic Acids Res; 2019 Aug; 47(14):e79. PubMed ID: 31045203
[TBL] [Abstract][Full Text] [Related]
9. Challenges and progress in interpretation of non-coding genetic variants associated with human disease.
Zhu Y; Tazearslan C; Suh Y
Exp Biol Med (Maywood); 2017 Jul; 242(13):1325-1334. PubMed ID: 28581336
[TBL] [Abstract][Full Text] [Related]
10. Limited statistical evidence for shared genetic effects of eQTLs and autoimmune-disease-associated loci in three major immune-cell types.
Chun S; Casparino A; Patsopoulos NA; Croteau-Chonka DC; Raby BA; De Jager PL; Sunyaev SR; Cotsapas C
Nat Genet; 2017 Apr; 49(4):600-605. PubMed ID: 28218759
[TBL] [Abstract][Full Text] [Related]
11. Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants.
Aune TM; Crooke PS; Patrick AE; Tossberg JT; Olsen NJ; Spurlock CF
J Autoimmun; 2017 Jul; 81():99-109. PubMed ID: 28420548
[TBL] [Abstract][Full Text] [Related]
12. Integrating regulatory features data for prediction of functional disease-associated SNPs.
Dong SS; Guo Y; Yao S; Chen YX; He MN; Zhang YJ; Chen XF; Chen JB; Yang TL
Brief Bioinform; 2019 Jan; 20(1):26-32. PubMed ID: 28968709
[TBL] [Abstract][Full Text] [Related]
13. Screening for functional transcriptional and splicing regulatory variants with GenIE.
Cooper SE; Schwartzentruber J; Bello E; Coomber EL; Bassett AR
Nucleic Acids Res; 2020 Dec; 48(22):e131. PubMed ID: 33152068
[TBL] [Abstract][Full Text] [Related]
14. Accurate eQTL prioritization with an ensemble-based framework.
Zeng H; Edwards MD; Guo Y; Gifford DK
Hum Mutat; 2017 Sep; 38(9):1259-1265. PubMed ID: 28224684
[TBL] [Abstract][Full Text] [Related]
15. The impact of different negative training data on regulatory sequence predictions.
Krützfeldt LM; Schubach M; Kircher M
PLoS One; 2020; 15(12):e0237412. PubMed ID: 33259518
[TBL] [Abstract][Full Text] [Related]
16. Systematic identification of regulatory variants associated with cancer risk.
Liu S; Liu Y; Zhang Q; Wu J; Liang J; Yu S; Wei GH; White KP; Wang X
Genome Biol; 2017 Oct; 18(1):194. PubMed ID: 29061142
[TBL] [Abstract][Full Text] [Related]
17. Running spell-check to identify regulatory variants.
Kircher M; Shendure J
Nat Genet; 2015 Aug; 47(8):853-5. PubMed ID: 26220134
[TBL] [Abstract][Full Text] [Related]
18. Genetic associations of breast and prostate cancer are enriched for regulatory elements identified in disease-related tissues.
Chen H; Kichaev G; Bien SA; MacDonald JW; Wang L; Bammler TK; Auer P; Pasaniuc B; Lindström S
Hum Genet; 2019 Oct; 138(10):1091-1104. PubMed ID: 31230194
[TBL] [Abstract][Full Text] [Related]
19. Regulatory genomic regions active in immune cell types explain a large proportion of the genetic risk of multiple sclerosis.
Elangovan RI; Disanto G; Berlanga-Taylor AJ; Ramagopalan SV; Handunnetthi L
J Hum Genet; 2014 Apr; 59(4):211-5. PubMed ID: 24522295
[TBL] [Abstract][Full Text] [Related]
20. Multi-locus test conditional on confirmed effects leads to increased power in genome-wide association studies.
Ma L; Han S; Yang J; Da Y
PLoS One; 2010 Nov; 5(11):e15006. PubMed ID: 21103364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
